Prosecution Insights
Last updated: April 19, 2026
Application No. 17/826,226

PATIENT MANAGEMENT SYSTEM

Non-Final OA §101§DP
Filed
May 27, 2022
Examiner
TIEDEMAN, JASON S
Art Unit
3683
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
ResMed
OA Round
3 (Non-Final)
29%
Grant Probability
At Risk
3-4
OA Rounds
4y 0m
To Grant
64%
With Interview

Examiner Intelligence

Grants only 29% of cases
29%
Career Allow Rate
101 granted / 343 resolved
-22.6% vs TC avg
Strong +35% interview lift
Without
With
+34.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
31 currently pending
Career history
374
Total Applications
across all art units

Statute-Specific Performance

§101
32.5%
-7.5% vs TC avg
§103
29.6%
-10.4% vs TC avg
§102
9.4%
-30.6% vs TC avg
§112
22.8%
-17.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 343 resolved cases

Office Action

§101 §DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION In the amendment dated 23 January 2026, the following occurred: Claims 40, 55, and 68 have been cancelled; Claims 73-78 are new. Claims 37-39, 41-54, 56-67, and 69-78 are pending. Priority This application claims priority to U.S. Patent No. 11,367,023 dated 61/780,640 dated 27 January 2017 which claims priority to PCT/US2015/043226 dated 31 July 2015 which claims priority to U.S. Provisional Patent Application No. 62/031,975 dated 01 August 2014. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 37-39, 41-54, 56-67, and 69-78 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. STEP 1 Claims 37, 52, and 65 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claims recite a system, method, and computer-readable medium (“CRM”) for managing patient compliance with respiratory pressure therapy, which are within a statutory class. STEP 2A1 The limitations of (Claim 52 being representative) receiving data concerning patient respiratory pressure therapy from a plurality of respiratory pressure therapy devices; generating a score for each of a plurality of patients receiving the respiratory pressure therapy based on the received data, wherein each score indicates a probability that a respective patient will meet a compliance standard, and wherein the compliance standard has a minimum amount of usage per session for a fraction of a number of consecutive sessions of respiratory pressure therapy; grouping the plurality of patients receiving the respiratory pressure therapy into a plurality of groups based on a time-based assessment of the received data, wherein the time-based assessment evaluates a period of days that each of the plurality of patients has been on the respiratory pressure therapy; generating […information…] representing the plurality of groups, wherein the plurality of groups is displayed, each […displayed group…] corresponding to a particular group; in response to user input, receiving a user selection of one group of the plurality of groups displayed, the user selection for activation of the one group; and generating upon activation of the one group […], a […] listing [of] a subset of the patients in the one group, wherein the subset of the patients in the one group are ranked […and displayed…] according to their scores, as drafted, is a process that, under the broadest reasonable interpretation, covers a method of organizing human activity (i.e., managing personal behavior including following rules or instructions) but for recitation of generic computer components. The claims encompass a series of rules or instructions for a person or persons to follow, with or without the aid of a computer, to managing patient compliance with respiratory pressure therapy (see Spec. Para. 0002) in the manner described in the identified abstract idea, supra. The rules or instructions are the claimed steps of “receive data…generate data…group data…receive data…and generate data,” as indicated supra. That is, other than reciting a system implemented by one or more processors or a CRM having graphical displays (discussed, infra), the claimed invention amounts to managing personal behavior or interaction between people. For example, but for the one or more processors or the CRM having graphical displays, the claims encompass a person collecting respiratory therapy data for patients, analyzing the patient data to create scores, grouping patients based on the scores, and outputting data based on the grouped scores in the manner described in the identified abstract idea, supra. The Examiner notes that Applicant has described monitoring of CPAP compliance as a product of CMS compliance standards promulgated by Medicaid (see Spec. Para. 0020). As the cited evidentiary references indicate, monitoring of CPAP usage for patients to determine whether CMS compliance standards are met is a human task performed by healthcare providers, i.e., sleep specialists (see Schwab et al. at Pg. 616; Continuous Positive Airway Pressure Devices & Accessories at Pg. 3; What Is CPAP Compliance? at Pg. 4). Further, and as is known in the art, healthcare providers (i.e., sleep specialists) routinely monitor multiple patients for CPAP compliance at the same time (see US 2008/0114689 to Psynik et al. at Fig. 5, Para. 0051; US2015/0154380 to Duckworth at Para. 0119, 0122, 0123), thus it is a human task. If a claim limitation, under its broadest reasonable interpretation, covers managing personal behavior or interactions between people but for the recitation of generic computer components, then it falls within the “method of organizing human activity” grouping of abstract ideas. Accordingly, the claim recites an abstract idea. STEP 2A2 This judicial exception is not integrated into a practical application. In particular, the claims recite the additional elements of one or more processors or a CRM having graphical displays that implements the identified abstract idea. The one or more processors or CRM having graphical displays are not described by the applicant and are recited at a high-level of generality (i.e., generic processors or storage device performing a generic computer functions) such that it amounts no more than mere instructions to apply the exception using a generic computer component. Accordingly, this additional element does not integrate the abstract idea into a practical application because it does not impose any meaningful limits on practicing the abstract idea. The claim is directed to an abstract idea. The claims further recite the additional elements of a plurality of respiratory pressure therapy devices. The respiratory pressure therapy devices represent locations from which data is received, which is a form of extra-solution data gathering activity. MPEP 2106.04(d)(I) indicates that merely adding insignificant extra-solution activity to the judicial exception cannot provide a practical application. Alternatively, the respiratory pressure therapy devices merely generally link the abstract idea to a particular technological environment or field of use. MPEP 2106.04(d)(I) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide a practical application. The claims further recite the additional elements of an array of selectable headings. The array of selectable headings (i.e., tabs) merely generally link the abstract idea to a particular technological environment or field of use. MPEP 2106.04(d)(I) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide a practical application. Given the broadest reasonable interpretation, the claim limitation of “upon activation” is interpreted as part of the rules or instructions for a person to follow, i.e., choosing to display information. In the event that this element can alternately be interpreted as an additional element outside of the abstract idea, the limitation represents extra-solution activity. MPEP 2106.04(d)(I) indicates that merely adding insignificant extra-solution activity to the judicial exception cannot provide a practical application. Accordingly, even in combination, these additional elements do not integrate the abstract idea into a practical application. STEP 2B The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional elements of using one or more processors or a CRM having graphical displays to perform the noted steps amounts to no more than mere instructions to apply the exception using a generic computer component. Mere instructions to apply an exception using a generic computer component cannot provide an inventive concept (“significantly more”). Also, as discussed above with respect to integration of the abstract idea into a practical application, the additional elements of a plurality of respiratory pressure therapy devices were considered to represent extra-solution data gathering activity. The Background section of Applicant’s Specification indicates that respiratory pressure therapy devices that output data are well-understood, routine, and conventional in the field. Further and for completeness, the prior art of record indicates that the receiving data from respiratory pressure therapy devices is well-understood, routine, and conventional in the field (see also, US 2008/0114689 to Psynik at Para. 0032, 0034, US 2015/0154380 to Duckworth at Para. 0127, WO 2004/110540 to Hebblewhite at Pg. 2, US 2014/0207476 to Fong at Para. 0133). Alternatively, the respiratory pressure therapy devices merely generally link the abstract idea to a particular technological environment or field of use. MPEP 2106.05(A) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide significantly more. Also, as discussed above with respect to integration of the abstract idea into a practical application, the additional elements of an array of selectable headings were considered to generally link the abstract idea to a particular technological environment or field of use. MPEP 2106.05(A) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide significantly more. Further and for completeness, the prior art of record indicates that an array of selectable headings is well-understood, routine, and conventional in the field. See US 2007/0088406 to Bennett et al. at Fig. 11, Para. 0051; US 2001/0040584 at Fig. 11, Para. 0047; US 2002/0004729 to Zak et al. at Para. 0078, Fig. 8; US 2008/0114689 to Psynik at Fig. 4A. Also, as discussed above with respect to integration of the abstract idea into a practical application, the claim limitation of “upon activation” was alternately interpreted extra-solution activity. The prior art of record indicates that graphical layouts displaying selectable data that is implemented “upon activation” is well-understood, routine, conventional activity in the field (see US 2008/0114689 to Psynik at Fig. 4A, WO 2004/110540 to Hebblewhite at Fig. 1, US 2016/0019351 to Ober at Fig. 11, Para. 0007, Claim 23, US 20150100327 to Kelley at Fig. 3A, 5). MPEP 2106.05(A) further indicates that well-understood, routine, and conventional activity of use cannot provide significantly more. Accordingly, even in combination, this additional element does not provide significantly more. As such the claim is not patent eligible. Claims 38, 39, 41-51, 53, 54, 56-64,66, 67, and 69-78 are similarly rejected because they either further define/narrow the abstract idea and/or do not further limit the claim to a practical application or provide as inventive concept such that the claims are subject matter eligible even when considered individually or as an ordered combination. Claim(s) 38, 53, 66 merely describe(s) the type of data received. Claim(s) 39, 54, 67 merely describe(s) data that is displayed, which further defines the abstract idea. Claim(s) 41, 42, 43, 44, 45, 46, 47, 48, 56, 57, 58, 59, 60, 61, 62, 63, 69, 70, 71, 73-78 merely describe(s) the data displayed and/or additional data that is displayed, which further defines the abstract idea. Claim(s) 41, 42, 43, 44, 45, 46, 48, 56, 57, 58, 59, 60, 61, 62, 63, 69, 70, 71, 73-78 also include features that occur “upon activation.” As with the independent claims, this is interpreted to be part of the rules or instructions for a person to follow, i.e., choosing to display or not display information. Alternately interpreting this feature as an additional element, the feature is interpreted in the same manner as the “upon activation” feature of Claim 37 and does not provide a practical application or significantly more for the same reasons. Claims 73-78 further recite the additional element of a graphical icon in the form of a checkbox. The icon in the form of a checkbox merely generally link the abstract idea to a particular technological environment or field of use. MPEP 2106.04(d)(I) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide a practical application. MPEP 2106.05(A) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide significantly more. Further, and for completeness, the prior art of record indicates that a selectable icon in the form of a checkbox is well-understood, routine, and conventional in the field. See US 2002/0116256 to De Rafael et al. at Para. 0031; US 2015/0356662 to Poole et al. at Para. 0060; US 2009/0248702 to Schwartz et al. at Para. 0085. Claim(s) 49, 64, 72 merely describe(s) what the score represents, which further defines the abstract idea. Claim(s) 50, 51 positively recites the additional elements of the respiratory pressure therapy devices being part of the system. These additional elements generally link the abstract idea to a particular technological environment or field of use. MPEP 2106.04(d)(I) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide a practical application. MPEP 2106.05(A) indicates that generally linking an abstract idea to a particular technological environment or field of use cannot provide significantly more. Accordingly, even in combination, this additional element does not provide a practical application or significantly more. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 37-39, 41-54, 56-67, and 69-78 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-30 of U.S. Patent No. 11,367,023. Although the claims at issue are not identical, they are not patentably distinct from each other because the claims recite determining compliance/usage information and displaying associated data in a manner that is an obvious variation on one another. Claims 37-39, 41-54, 56-67, and 69-78 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claim 1-36 of copending Application No. 18/828,543 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because the claims recite determining compliance/usage information and displaying associated data in a manner that is an obvious variation on one another. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Response to Arguments Double Patenting Regarding the rejection of Claim 37-72, the Applicant has cancelled Claims 40, 55, and 68 rendering the rejection of those claims moot. Regarding the remaining claims, the Applicant requests reconsideration of the rejection or that the rejection be held in abeyance. The Examiner has reconsidered the rejections and finds it to be proper. Further, the rejection cannot be held in abeyance. See MPEP 804 (“As filing a terminal disclaimer, or filing a showing that the claims subject to the rejection are patentably distinct from the reference application’s claims, is necessary for further consideration of the rejection of the claims, such a filing should not be held in abeyance. Only compliance with objections or requirements as to form not necessary for further consideration of the claims may be held in abeyance until allowable subject matter is indicated.”). Therefore, the rejection is maintained. Rejection under 35 U.S.C. § 101 Regarding the rejection of Claims 37-72, the Applicant has cancelled Claims 40, 55, and 68 rendering the rejection of those claims moot. Regarding the remaining claims, the Examiner has considered the Applicant’s arguments; however, the arguments are not persuasive. Applicant argues: The Examiner[, in reference to the arguments presented in reference to Example 37] asserts that Applicant has not identified "any particular GUI-related problem" and that the meaningful distinction in the cited cases is improvement to disclosed GUI problems. However, this premise is misplaced for at least two reasons: (i) Applicant did identify a concrete need in the disclosure, and (ii) the claims go beyond mere "displaying information", and execute a computing integrated therapy-intervention workflow in which an interface enables a user to achieve visualization of patient information that is uniquely organized in a manner that presents most significant information according to a ranking where that information becomes most useful. Regarding (a), the Examiner respectfully disagrees. As quoted by the Applicant, Example 37 states “[t]aditionally, computer users are limited in the ways in which they can organize icons on their display.” This problem arises because of the computer; it is a technical problem caused by the technological environment to which the claims are confined—the computer. Applicant’s “concrete need” is not a problem caused by the computer. The cited portion of the Specification at Para. 0022 describes a non-technical problem. The technological environment to which Applicant’s claims are confined (a generic computer) did not cause this problem. It exists independent of the computer. This is bolstered by Spec. Para. 0021 which states: Many CPAP patients are therefore missing out on beneficial therapy for reasons that are avoidable if their DME had access to timely information about the progress of their therapy and any difficulties they are experiencing. The data management capability of RPT devices described above may enable such access by DMEs. However, if simply presented with raw therapy data from the potentially large number of CPAP patients under their care, an agent of a DME may have no idea which patients have compliance issues and which do not. As indicated by the Applicant, this is not a problem caused by the computer. The Examiner does not dispute that Applicant’s claims provide a technological solution (“go beyond mere ‘displaying information’”); however, this is a solution to a non-technical problem. Because there is no technological problem and Applicant fails to meet this test for a practical application. As noted above, there is also no meaningful distinction between, for example, claim 37 of the present application and the claims at issue in Trading Technologies. Regarding (b), the Examiner respectfully disagrees. Initially, the Examiner notes that Trading Tech. v. CQG is a non-precedential decision and therefore is specific to the facts of the case. It is non-precedential for a reason. In any event, the meaningful distinction is that the claims in Trading Tech. v. CQG were solving described problems with current GUI devices at the time of the invention. Applicant has not identified nor can the Examiner locate any particular GUI-related problem that was caused by the claimed device that Applicant’s claims are solving. As quoted by the Applicant, Trading Tech. described a “a specifically identified problem in the prior state of the art." The claims in Trading Tech. “solve problems of prior graphical user interface devices . . . in the context of computerized trading[] relating to speed, accuracy and usability.” Trading Tech. slip op. at 6. The problem caused by the graphical user interface devices was that they were unable to keep up with rapid market movement. Trading Tech. slip op. at 3. This was a problem caused by the device; a technical problem. The claims in Trading Tech. then solved this problem by claiming a way for “for reducing the time it takes for a trader to place a trade when electronically trading on an exchange.” Trading Tech. slip op. at 3. This was the technical solution. As with argument (a), Applicant has not identified a technological problem caused by the computer. As noted above, there is also no meaningful eligibility distinction between, for example, claim 37 or 73 of the present application and the claims at issue in Core Wireless [or Data Engine Techs.]. Regarding (C), the Examiner respectfully disagrees. The meaningful distinction is that the claims in the argued examples (Core Wireless and/or Data Engine Techs.) were an improvement to disclosed problems with user interfaces at the time of the invention. Applicant has not identified nor can the Examiner locate any discussion in Applicant’s disclosure of any problem with displaying information caused by the computer. Previous responses to this same argument are incorporated herein. Applicant notes that even if, arguendo, Applicant's claims are only directed to a "graphic user interface" (which Applicant does not concede), the PTO confirms the eligibility of this subject matter in the MPEP 2106.04(a)(l): Non-limiting hypothetical examples of claims that do not recite (set forth or describe) an abstract idea include: […] vi. a method of rearranging icons. […] The aforementioned graphic user interface example that is confirmed by the PTO as not reciting an abstract idea, involves a graphic user interface to the extent as alleged in the Office Action regarding claim 1. Regarding (d), the Examiner respectfully disagrees. Initially, the Examiner has not characterized the claims as “only directed to a ‘graphic user interface,’" as is eminently clear in the basis of rejection. Be that as it may, the claims in the cited example were found to not be directed to an abstract idea. Applicant’s claims are directed to an abstract idea and therefore this argument falls on its face. Nevertheless, even despite the absence of an abstract idea, Applicant's claimed graphic user interface aspect also presents an improvement to a field of technology. […] Examples that the courts have indicated may be sufficient to show an improvement in existing technology include: […] viii. A specific, structured graphical user interface that improves the accuracy of trader transactions by displaying bid and asked prices in a particular manner that prevents order entry at a changed price, Trading Techs. Int'l, Inc. v. CQG, Inc., 675 Fed. App'x 1001 (Fed. Cir. 2017) (non-precedential); ... Regarding (e), the Examiner respectfully disagrees. Initially, the Examiner notes that Applicant’s claims are directed to an abstract idea as described in the basis of rejection. The claims are also not an improvement as in Trading Tech. as no technological problem is solved. See discussion, supra. Moreover, as indicated by a lack of prior art rejections, it is not conventional, and indeed is novel and inventive. Regarding (f), the Examiner respectfully submits that the rejection never stated that the abstract idea was well-understood, routine, and conventional nor is such a showing required. MPEP 2106.05(d) states: “Another consideration when determining whether a claim recites significantly more than a judicial exception is whether the additional element(s) are well-understood, routine, conventional activities previously known to the industry (emphasis added).” All of the additional elements that were characterized as extra-solution activity were analyzed and determined to be well-understood, routine, conventional, as described in the basis of rejection. Further, MPEP 2106.05(I) states: “As made clear by the courts, the novelty of any element or steps in a process, or even of the process itself, is of no relevance in determining whether the subject matter of a claim falls within the § 101 categories of possibly patentable subject matter (internal quotations omitted, emphasis original).” Thus, whether or not the abstract idea is not taught by the prior art is immaterial to the subject matter eligibility analysis. In that regard, MPEP 2106.05(d)(I) indicates that in determining whether the additional elements represent are well-understood, routine, conventional activities, the Examiner should consider whether the additional elements (1) provide an improvement to the technological environment to which the claim is confined, (2) whether the additional elements are mere instructions to apply the judicial exception, or (3) whether the additional elements represent insignificant extra-solution activity. The additional elements of the claims do not provide significantly more based on this inquiry. They are also well-understood, routine, and conventional as indicated by the prior art of record. Where Applicant’s assertion true, the claims at issue in the Alice Corp. decision would have been eligible because the claims were issued. This is clearly an incorrect argument. Interview Request Applicant states: If, however, for any reason the Examiner does not believe that such action [allowance] can be taken at this time, it is respectfully requested that the Examiner telephone Applicant's attorney at (908) 73 8-1780 in order to overcome any additional objections which the Examiner might have. The Examiner declines this request. The Examiner does not have any suggestions. Conclusion Prior art made of record though not relied upon in the present basis of rejection are noted in the attached PTO 892 and include: Lynch, Jr. (U.S. Pre-Grant Patent Publication No. 2012/0247472) which discloses a method for treating sleep disorders using an algorithm that analyzes sleep patterns and provides treatment via an auto-titrator. DeVille et al. (U.S. Pre-Grant Patent Publication No. 2014/0052466) which discloses a system for reducing fraudulent reimbursement for durable medical equipment such as a CPAP. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JASON S TIEDEMAN whose telephone number is (571)272-4594. The examiner can normally be reached 7:00am-4:00pm, off alternate Fridays. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Morgan can be reached at 571-272-6773. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JASON S TIEDEMAN/Primary Examiner, Art Unit 3683
Read full office action

Prosecution Timeline

May 27, 2022
Application Filed
Aug 29, 2024
Response after Non-Final Action
Mar 27, 2025
Non-Final Rejection — §101, §DP
Sep 10, 2025
Applicant Interview (Telephonic)
Sep 10, 2025
Examiner Interview Summary
Sep 18, 2025
Response Filed
Oct 21, 2025
Final Rejection — §101, §DP
Jan 23, 2026
Request for Continued Examination
Feb 11, 2026
Response after Non-Final Action
Mar 12, 2026
Non-Final Rejection — §101, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12592304
Rules-Based Processing of Structured Data
2y 5m to grant Granted Mar 31, 2026
Patent 12558476
INFUSION PUMP ADMINISTRATION SYSTEM
2y 5m to grant Granted Feb 24, 2026
Patent 12562254
SURGICAL DATA SPECIALTY HARMONIZATION FOR TRAINING MACHINE LEARNING MODELS
2y 5m to grant Granted Feb 24, 2026
Patent 12561657
SYSTEMS AND METHODS FOR ALLOCATING RESOURCES VIA INFORMATION TECHNOLOGY INFRASTRUCTURE
2y 5m to grant Granted Feb 24, 2026
Patent 12531156
METHOD FOR ADVANCED ALGORITHM SUPPORT
2y 5m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
29%
Grant Probability
64%
With Interview (+34.8%)
4y 0m
Median Time to Grant
High
PTA Risk
Based on 343 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month